Sort
38,696 grants matching “als”
Deciphering Pathways Driving Inflammatory Fibroblast Effector Functions in RA
$383,789Michael B Brenner · Brigham And Women'S Hospital · R01 · FY2019 · AR
Molecular Basis of Sensory Transduction in C. elegans
$383,759Miriam B Goodman · Stanford University · R01 · FY2009 · NS
Rivastigmine as a Treatment for Methamphetamine Dependence
$383,750Richard De La Garza · Baylor College Of Medicine · R01 · FY2008 · DA
Animal Models for Lipid Metabolism and Atherosclerosis
$383,750Lawrence Chan · Baylor College Of Medicine · R01 · FY2010 · HL
Rivastigmine as a Treatment for Methamphetamine Dependence
$383,750Richard De La Garza · Baylor College Of Medicine · R01 · FY2009 · DA
Targeting STAU1 for TDP-43 proteinopathies
$383,748Daniel R Scoles · University Of Utah · R61 · FY2022 · NS
GLUTATHIONE DEPLETION AND MITOCHONDRIAL COMPLEX I DYSFUNCTION
$383,672Julie Kay Andersen · Buck Institute For Research On Aging · P01 · FY2009 · AG
C6ORF32, AN HDAC6-BINDING PROTEIN THAT REGULATES MYOBLAST DIFFERENTIATION
$383,670Emanuela Gussoni · Boston Children'S Hospital · R01 · FY2014 · AR
High Mobility Group A1 Chromatin Regulators in Colon Carcinogenesis
$383,665Linda M S Resar · Johns Hopkins University · R01 · FY2019 · CA
DEPRESSION AND END OF LIFE CARE IN ALS
$383,625Columbia University Health Sciences · R01 · FY2001 · MH
DEPRESSION AND END OF LIFE CARE IN ALS
$383,625Columbia University Health Sciences · R01 · FY2002 · MH
DEPRESSION AND END OF LIFE CARE IN ALS
$383,625Columbia University Health Sciences · R01 · FY2000 · MH
Structural Correlates of Knee Pain
$383,618David Tobin Felson · Boston University Medical Campus · R01 · FY2007 · AR
Experimental Evidence on the Effects of Academic Remediation on Violence
$383,599Jens Ludwig · University Of Chicago · R01 · FY2023 · CE
RFA-CE-23-004 Experimental Evidence on the Effects of Academic Remediation on Violence
$383,599Jens Ludwig · University Of Chicago · R01 · FY2025 · CE
Regulatory mechanisms and role of the PI3K-TSC-mTOR signaling network in tumors
$383,563Brendan D. Manning · Harvard School Of Public Health · R01 · FY2015 · CA
Novel Vaccine Strategies Against Ebola Virus
$383,527Richard W Compans · Emory University · R01 · FY2008 · AI
Community-Based Kiosks for Hearing Screening and Education
$383,488M Patrick Feeney · Oregon Health & Science University · R33 · FY2016 · DC
Emory Alzheimer's Disease Research Center
$383,484Jonathan David Glass · Emory University · P30 · FY2024 · AG
HIV/STD Prevention Program for African American Males
$383,448Stephen B. Kennedy · Pacific Institute For Res And Evaluation · R01 · FY2011 · MD
Population receptive field analysis in subjects with area V1+ lesions.
$383,425Stelios Manolis Smirnakis · Baylor College Of Medicine · R01 · FY2015 · EY
Broad-Range VLP Vaccine Against H5N1 Influenza
$383,409Peter M. Pushko · Medigen, Inc. · R01 · FY2017 · AI
A Novel Pharmacotherapy for Alcoholism: Evaluation of Reward, Aversion, Compulsivity, Withdrawal & Reinstatement
$383,400Abraham A Palmer · University Of California, San Diego · R01 · FY2019 · AA
A Novel Pharmacotherapy for Alcoholism: Evaluation of Reward, Aversion, Compulsivity, Withdrawal & Reinstatement
$383,400Abraham A Palmer · University Of California, San Diego · R01 · FY2020 · AA
A Novel Pharmacotherapy for Alcoholism: Evaluation of Reward, Aversion, Compulsivity, Withdrawal & Reinstatement
$383,400Abraham A Palmer · University Of California, San Diego · R01 · FY2022 · AA